Litcius/Paper detail

VEGF and Neuronal Survival

Paula M. Calvo, Rosendo G. Hernández, Ángel M. Pastor, Rosa R. de la Cruz

2022The Neuroscientist26 citationsDOIOpen Access PDF

Abstract

Vascular endothelial growth factor (VEGF) is well known for its angiogenic activity, but recent evidence has revealed a neuroprotective action of this factor on injured or diseased neurons. In the present review, we summarize the most relevant findings that have contributed to establish a link between VEGF deficiency and neuronal degeneration. At issue, 1) mutant mice with reduced levels of VEGF show adult-onset muscle weakness and motoneuron degeneration resembling amyotrophic lateral sclerosis (ALS), 2) administration of VEGF to different animal models of motoneuron degeneration improves motor performance and ameliorates motoneuronal degeneration, and 3) there is an association between low plasmatic levels of VEGF and human ALS. Altogether, the results presented in this review highlight VEGF as an essential motoneuron neurotrophic factor endowed with promising therapeutic potential for the treatment of motoneuron disorders.

Topics & Concepts

Amyotrophic lateral sclerosisNeuroprotectionDegeneration (medical)Vascular endothelial growth factorNeuroscienceNeurotrophic factorsVEGF receptorsNeurotrophinMedicineNeuronal degenerationNeurodegenerationMotor neuronBiologyPathologyInternal medicineDiseaseReceptorSpinal cordHistone Deacetylase Inhibitors ResearchAmyotrophic Lateral Sclerosis ResearchAngiogenesis and VEGF in Cancer
VEGF and Neuronal Survival | Litcius